These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 20653464)

  • 1. A formulation comparison between micro- and nanosuspensions: the importance of particle size for absorption of a model compound, following repeated oral administration to rats during early development.
    Sigfridsson K; Nordmark A; Theilig S; Lindahl A
    Drug Dev Ind Pharm; 2011 Feb; 37(2):185-92. PubMed ID: 20653464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Particle size reduction and pharmacokinetic evaluation of a poorly soluble acid and a poorly soluble base during early development.
    Sigfridsson K; Lundqvist AJ; Strimfors M
    Drug Dev Ind Pharm; 2011 Mar; 37(3):243-51. PubMed ID: 21073318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Particle size reduction for improvement of oral absorption of the poorly soluble drug UG558 in rats during early development.
    Sigfridsson K; Lundqvist AJ; Strimfors M
    Drug Dev Ind Pharm; 2009 Dec; 35(12):1479-86. PubMed ID: 19929207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and in vitro/in vivo evaluation of nano-sized crystals for dissolution rate enhancement of ucb-35440-3, a highly dosed poorly water-soluble weak base.
    Hecq J; Deleers M; Fanara D; Vranckx H; Boulanger P; Le Lamer S; Amighi K
    Eur J Pharm Biopharm; 2006 Nov; 64(3):360-8. PubMed ID: 16846725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs.
    Hu L; Tang X; Cui F
    J Pharm Pharmacol; 2004 Dec; 56(12):1527-35. PubMed ID: 15563759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring solid lipid nanoparticles to enhance the oral bioavailability of curcumin.
    Kakkar V; Singh S; Singla D; Kaur IP
    Mol Nutr Food Res; 2011 Mar; 55(3):495-503. PubMed ID: 20938993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solution calorimetry as an alternative approach for dissolution testing of nanosuspensions.
    Kayaert P; Li B; Jimidar I; Rombaut P; Ahssini F; Van den Mooter G
    Eur J Pharm Biopharm; 2010 Nov; 76(3):507-13. PubMed ID: 20887787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo evaluation of silybin nanosuspensions for oral and intravenous delivery.
    Wang Y; Zhang D; Liu Z; Liu G; Duan C; Jia L; Feng F; Zhang X; Shi Y; Zhang Q
    Nanotechnology; 2010 Apr; 21(15):155104. PubMed ID: 20332565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding a relaxation behavior in a nanoparticle suspension for drug delivery applications.
    Deng Z; Xu S; Li S
    Int J Pharm; 2008 Mar; 351(1-2):236-43. PubMed ID: 18093763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation of stable nitrendipine nanosuspensions using the precipitation-ultrasonication method for enhancement of dissolution and oral bioavailability.
    Xia D; Quan P; Piao H; Piao H; Sun S; Yin Y; Cui F
    Eur J Pharm Sci; 2010 Jul; 40(4):325-34. PubMed ID: 20417274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vitro and In Vivo Characterization of Drug Nanoparticles Prepared Using PureNano™ Continuous Crystallizer to Improve the Bioavailability of Poorly Water Soluble Drugs.
    Tahara K; Nishikawa M; Matsui K; Hisazumi K; Onodera R; Tozuka Y; Takeuchi H
    Pharm Res; 2016 Sep; 33(9):2259-68. PubMed ID: 27301372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of hydrophobins in formulation of water insoluble drugs for oral administration.
    Haas Jimoh Akanbi M; Post E; Meter-Arkema A; Rink R; Robillard GT; Wang X; Wösten HA; Scholtmeijer K
    Colloids Surf B Biointerfaces; 2010 Feb; 75(2):526-31. PubMed ID: 19836932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of oral bioavailability of an HIV-attachment inhibitor by nanosizing and amorphous formulation approaches.
    Fakes MG; Vakkalagadda BJ; Qian F; Desikan S; Gandhi RB; Lai C; Hsieh A; Franchini MK; Toale H; Brown J
    Int J Pharm; 2009 Mar; 370(1-2):167-74. PubMed ID: 19100319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic evaluation of oral fenofibrate nanosuspensions and SLN in comparison to conventional suspensions of micronized drug.
    Hanafy A; Spahn-Langguth H; Vergnault G; Grenier P; Tubic Grozdanis M; Lenhardt T; Langguth P
    Adv Drug Deliv Rev; 2007 Jul; 59(6):419-26. PubMed ID: 17566595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lopinavir loaded solid lipid nanoparticles (SLN) for intestinal lymphatic targeting.
    Aji Alex MR; Chacko AJ; Jose S; Souto EB
    Eur J Pharm Sci; 2011 Jan; 42(1-2):11-8. PubMed ID: 20971188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanosuspension as an ophthalmic delivery system for certain glucocorticoid drugs.
    Kassem MA; Abdel Rahman AA; Ghorab MM; Ahmed MB; Khalil RM
    Int J Pharm; 2007 Aug; 340(1-2):126-33. PubMed ID: 17600645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alginate microspheres of isoniazid for oral sustained drug delivery.
    Rastogi R; Sultana Y; Aqil M; Ali A; Kumar S; Chuttani K; Mishra AK
    Int J Pharm; 2007 Apr; 334(1-2):71-7. PubMed ID: 17113732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastrointestinal distribution and in vivo gene transfection studies with nanoparticles-in-microsphere oral system (NiMOS).
    Bhavsar MD; Amiji MM
    J Control Release; 2007 Jun; 119(3):339-48. PubMed ID: 17475358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suspensions for intravenous (IV) injection: a review of development, preclinical and clinical aspects.
    Wong J; Brugger A; Khare A; Chaubal M; Papadopoulos P; Rabinow B; Kipp J; Ning J
    Adv Drug Deliv Rev; 2008 May; 60(8):939-54. PubMed ID: 18343527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling the influence of cyclodextrins on oral absorption of low-solubility drugs: I. Model development.
    Gamsiz ED; Miller L; Thombre AG; Ahmed I; Carrier RL
    Biotechnol Bioeng; 2010 Feb; 105(2):409-20. PubMed ID: 19725042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.